Pierce, J. B., Li, Z., Greiner, M. A., Lippmann, S. J., Hardy, N. C., Shen, X., … Greene, S. J. (2023). Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry. Circ Heart Fail, 16(1), e010176. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010176

Pierce, Jacob B., Zhen Li, Melissa A. Greiner, Steven J. Lippmann, N Chantelle Hardy, Xian Shen, Mark Stampehl, et al. “Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry.” Circ Heart Fail 16, no. 1 (January 2023): e010176. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010176.

Pierce JB, Li Z, Greiner MA, Lippmann SJ, Hardy NC, Shen X, et al. Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2023 Jan;16(1):e010176.

Pierce, Jacob B., et al. “Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry.” Circ Heart Fail, vol. 16, no. 1, Jan. 2023, p. e010176. Pubmed, doi:10.1161/CIRCHEARTFAILURE.122.010176.

Pierce JB, Li Z, Greiner MA, Lippmann SJ, Hardy NC, Shen X, Stampehl M, Mentz RJ, Allen LA, Peterson PN, Fonarow GC, O’Brien EC, Greene SJ. Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2023 Jan;16(1):e010176.